Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Vascular and Endovascular Surgery|October 23, 2020
Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery DiseaseE Hope Weissler, Dennis I Narcisse, Jennifer A Rymer, et al.
American Heart Journal|June 22, 2015
The choice of arterial access for percutaneous coronary intervention and its impact on outcome: An expert opinion perspectiveNevin C Baker, Gary M Ansel, Sunil V Rao, et al.
Clinical Cardiology|August 12, 2020
The impact of chronic kidney disease on outcomes following peripheral vascular interventionDennis I Narcisse, Elizabeth Hope Weissler, Jennifer A Rymer, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 3, 2018
Design Strategies for Global Clinical Trials of Endovascular Devices for Critical Limb Ischemia (CLI) - A Joint USA-Japanese PerspectiveHiroyoshi Yokoi, Mami Ho, Shin Iwamoto, et al.
Circulation. Cardiovascular Interventions|September 29, 2011
Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study resultsMichael D Dake, Gary M Ansel, Michael R Jaff, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 13, 2019
Final Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary EmbolismMichael D Dake, Timothy P Murphy, Albrecht H Krämer, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 5, 2018
One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava FilterMichael D Dake, Timothy P Murphy, Albrecht H Krämer, et al.
Circulation|May 7, 2020
Mortality and Paclitaxel-Coated Devices: An Individual Patient Data Meta-AnalysisKrishna J Rocha-Singh, Sue Duval, Michael R Jaff, et al.
Pageof 10